Emerging technologies & innovation systems

Innogen co-director Joyce Tait gave a keynote presentation at the virtual Bloomsbury SET conference focused on infectious diseases and antimicrobial resistance. Her talk in the first session of the conference: “Interdisciplinary knowledge exchange to tackle global health challenges” highlighted some of the Innogen’s work on regulatory adaptation to support the development of new antimicrobial drugs and rapid diagnostics.

We have learned with the greatest sadness of the passing of Andrew Webster, Professor in sociology at the University of York.

Speaking to reporter Max Stephens from The Daily Telegraph, Innogen’s Founding Director, said that rejecting the legislation currently under consideration in England that will allow gene-edited products to be grown and sold, will mean Scotland will lose out.

Joyce Tait contributed to the assessment of the regulatory landscape for the life sciences sector in the ‘Pro-Innovation Regulation of Technologies Review’, which was presented by Professor Dame Angela McLean, the new UK Government Chief Scientific Adviser, to the Chancellor of the Exchequer and to HM Government.

As part of the ESRC Festival of Social Science, the Innogen Institute brought together social science researchers and scientists from the Roslin Institute and the Centre for Synthetic and Systems Biology (SynthSys) at the University of Edinburgh for a free public event exploring the opportunities arising from the latest genetic technologies and the regulatory issues they are facing.